Patents by Inventor Kathleen Stringer

Kathleen Stringer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SERUM METABOLITES AS BIOMARKERS FOR CARNITINE TREATMENT OF SEPSIS
    Publication number: 20230130325
    Abstract: Provided herein is technology relating to treating septic shock and particularly, but not exclusively, to methods and systems for identifying sepsis patients most likely to benefit from L-carnitine treatment.
    Type: Application
    Filed: March 30, 2021
    Publication date: April 27, 2023
    Inventors: Michael A. PUSKARICH, ALAN E. JONES, CHRISTOPHER E. GILLIES, THEODORE S. JENNARO, KATHLEEN A. STRINGER
  • Markers for sepsis treatment
    Patent number: 10330685
    Abstract: Provided herein is technology relating to treatment of sepsis and particularly, but not exclusively, to methods for predicting a response of a sepsis patient to treatment with L-carnitine.
    Type: Grant
    Filed: April 28, 2015
    Date of Patent: June 25, 2019
    Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
    Inventors: Kathleen Stringer, Alan E. Jones, Mike Puskarich
  • MARKERS FOR SEPSIS TREATMENT
    Publication number: 20170052192
    Abstract: Provided herein is technology relating to treatment of sepsis and particularly, but not exclusively, to methods for predicting a response of a sepsis patient to treatment with L-carnitine.
    Type: Application
    Filed: April 28, 2015
    Publication date: February 23, 2017
    Inventors: Kathleen STRINGER, Alan E. JONES, Mike PUSKARICH
  • COMPOSITIONS AND METHODS FOR DELIVERING PHARMACEUTICAL AGENTS
    Publication number: 20160220710
    Abstract: Provided herein are microcrystalline forms of drugs. In particular, provided herein are microcrystalline drug formulations for delivery to macrophages and treatment of disease.
    Type: Application
    Filed: January 29, 2016
    Publication date: August 4, 2016
    Inventors: Rahul K. Keswani, Gi S. Yoon, Kathleen Stringer, Gustavo Rosania, Chao Tian, Xueding Wang
  • Formulations for pulmonary delivery
    Publication number: 20030113271
    Abstract: Formulations for pulmonary delivery that include a protein and a non-physiological surfactant at or above the CMC of the surfactant, and methods for preparing and using the same.
    Type: Application
    Filed: December 24, 2002
    Publication date: June 19, 2003
    Applicant: University Technology Corporation
    Inventors: Derrick Katyama, Mark C. Manning, Kathleen A. Stringer, John E. Repine
  • Plasminogen activator as an anti-inflammatory agent
    Patent number: 6497877
    Abstract: Plasminogen activator acts as an anti-inflammatory agent by inhibiting generation of superoxide anion by a mechanism that is not related to L-arginine, is not dependent on thrombolytic activity, and is not a function of oxygen free radical scavenging. Moreover, in in vivo models of inflammation, treatment with plasminogen activator reduces edema without inhibiting neutrophil infiltration in in vivo models of inflammation.
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: December 24, 2002
    Assignee: University Technology Corporation
    Inventors: Kathleen A. Stringer, Brooks M. Hybertson, John E. Repine, Joe M. McCord